Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
OCGN
OCGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
OCGN News
U.S. Equities Semi-Annual Rebalancing Begins
1d ago
seekingalpha
FTSE Russell Microcap Index Reconstitution Begins
1d ago
seekingalpha
Ocugen Closes $130 Million Convertible Notes Offering
May 14 2026
Newsfilter
Hantavirus Outbreak Sparks Rally in Biotech Stocks
May 13 2026
Fool
Ocugen Reports Q1 2026 Earnings with Strategic Updates
May 05 2026
seekingalpha
Ocugen Reports Wider Q1 Losses, Shares Drop Over 19%
May 05 2026
seekingalpha
Ocugen Prices $115M Convertible Senior Notes Offering
May 05 2026
seekingalpha
Ocugen Reports Q1 Earnings with Revenue Beat and Cash Runway Extension
May 05 2026
seekingalpha
Ocugen Reports Positive Data from OCU410 Clinical Trial for Geographic Atrophy
May 05 2026
Newsfilter
Ocugen Plans to Offer $115 Million Convertible Senior Notes
May 05 2026
NASDAQ.COM
Ocugen to Announce Q1 Earnings on May 5th
May 04 2026
seekingalpha
Avaí Bio Advances Cell Therapy for Aging
Apr 10 2026
PRnewswire
Avaí Bio and Austrianova Advance Anti-Aging Therapy Collaboration
Apr 10 2026
Newsfilter
Ocugen Completes Enrollment for OCU410ST Clinical Trial
Apr 01 2026
Newsfilter
Ocugen Reports Phase 2 Data for OCU410 Gene Therapy
Mar 24 2026
seekingalpha
OCGN Stock Plummets Following Gene Therapy Trial News — What Did Ocugen Reveal?
Mar 24 2026
stocktwits
Show More News
